# A Study to Evaluate the Safety and Efficacy of CBD-OS in Participants With DEE

> **NCT07723976** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Jazz Pharmaceuticals** · enrollment: 120 (estimated)

## Conditions studied

- Developmental and Epileptic Encephalopathy (DEE)

## Interventions

- **DRUG:** CBD-OS
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07723976
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-30
- **Primary completion:** 2029-09-04
- **Final completion:** 2029-09-04
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07723976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07723976, "A Study to Evaluate the Safety and Efficacy of CBD-OS in Participants With DEE". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07723976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*